D89.42 ICD-10-CM Code: Idiopathic mast cell activation syndrome
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Inpatient Payment Groups (MS-DRG)
MS-DRGs this diagnosis helps define, as principal or secondary, per the CMS ICD-10-CM/PCS MS-DRG Definitions Manual v43.0, Appendix B.
- MS-DRG 814 — RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC (MDC 16)
- MS-DRG 815 — RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC (MDC 16)
- MS-DRG 816 — RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC (MDC 16)
A diagnosis appearing in a group's logic does not by itself determine the DRG assigned to a stay; the grouper uses the full claim.
Official Registry Overview & Definition
Official Tabular Instructional Notes
Sequencing, inclusion, and exclusion notes published for D89.42 in the official ICD-10-CM tabular list.
Includes
Conditions the official ICD-10-CM tabular list includes under this code.
- defects in the complement system
- immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
- sarcoidosis
Excludes1 — Not Coded Here
Conditions generally not reported together with this code (Excludes1) -- an error unless the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
- aggressive systemic mastocytosis (C96.21) Compare D89.42 vs C96.21 →
- congenital cutaneous mastocytosis (Q82.2) Compare D89.42 vs Q82.2 →
- (non-congenital) cutaneous mastocytosis (D47.01) Compare D89.42 vs D47.01 →
- (indolent) systemic mastocytosis (D47.02) Compare D89.42 vs D47.02 →
- malignant mast cell neoplasm (C96.2-) Compare D89.42 vs C96.2 →
- malignant mastocytoma (C96.29) Compare D89.42 vs C96.29 →
- mast cell leukemia (C94.3-) Compare D89.42 vs C94.3 →
- mast cell sarcoma (C96.22) Compare D89.42 vs C96.22 →
- mastocytoma NOS (D47.09) Compare D89.42 vs D47.09 →
- other mast cell neoplasms of uncertain behavior (D47.09) Compare D89.42 vs D47.09 →
- systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02) Compare D89.42 vs D47.02 →
- hyperglobulinemia NOS (R77.1) Compare D89.42 vs R77.1 →
- monoclonal gammopathy (of undetermined significance) (D47.2) Compare D89.42 vs D47.2 →
- autoimmune disease (systemic) NOS (M35.9) Compare D89.42 vs M35.9 →
- functional disorders of polymorphonuclear neutrophils (D71-) Compare D89.42 vs D71 →
Excludes2 — Not Included Here
Conditions not covered by this code, but which may be reported alongside it when both are present.
- transplant failure and rejection (T86.-) Compare D89.42 vs T86 →
- human immunodeficiency virus [HIV] disease (B20) Compare D89.42 vs B20 →
Indexed Clinical Terms (1)
Clinical term phrases from the official ICD-10-CM Index to Diseases and Injuries that map to this code.
- Activation, mast cell (disorder) (syndrome), idiopathic
Frequently Compared Codes
The official Excludes notes on D89.42 name these codes. Each comparison page covers when the two can — or must not — be reported together.
Change history
- FY2027 — 2026-10-01Excludes2 note addedhuman immunodeficiency virus [HIV] disease (B20)FY2027 changes
- FY2027 — 2026-10-01Excludes1 note removedhuman immunodeficiency virus [HIV] disease (B20)FY2027 changes
- FY2017 — 2016-10-01Added to the code setIdiopathic mast cell activation syndromeFY2017 changes
Verify Before Coding
- No Medicare Code Editor or MS-DRG Definitions Manual restrictions apply to this code.
From the code registry, the Medicare Code Editor, and the MS-DRG Definitions Manual. Check it against a full claim.
Relationships & Classification
Clinical classification (AHRQ CCSR):BLD008 — Immunity disorders (default).
Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality.
Potential MS-DRG Relationships (FY2026)
Not on the CMS CC/MCC list — as a secondary diagnosis this code does not change MS-DRG severity.
Named in the grouper logic of 3 MS-DRGs: DRG 814 (MDC 16), DRG 815 (MDC 16), DRG 816 (MDC 16).
From the CMS MS-DRG Definitions Manual (Appendices B and C). Actual DRG assignment depends on the complete claim.
Contextual Map
Every relationship of D89.42 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Hierarchy
- D50-D89 — Chapter 3: Diseases of the Blood and Blood-forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) (D50-D89) [Hierarchy]
Clinical classification (CCSR)
- BLD008 — Immunity disorders [CCSR]
Potential MS-DRG
- DRG 814 — RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC [MS-DRG]: “RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC (MDC 16)”
- DRG 815 — RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC [MS-DRG]: “RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC (MDC 16)”
- DRG 816 — RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC [MS-DRG]: “RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC (MDC 16)”
MDC crossing · procedures (1614)
- MDC 16 — Diseases and Disorders of Blood, Blood Forming Organs and Immunologic Disorders [MDC crossing]: “Diseases and Disorders of Blood, Blood Forming Organs and Immunologic Disorders — the grouper's crossing between diagnoses and procedures: a principal diagnosis sets the MDC, and same-MDC procedures move the stay to its surgical DRGs.”
- 02HV02Z — Insertion of Monitoring Device into Superior Vena Cava, Open Approach [Same-MDC procedure]: “Insertion of Monitoring Device into Superior Vena Cava, Open Approach — grouped in MDC 16, the procedure side of this code's crossing.” · check together
- 02HV0DZ — Insertion of Intraluminal Device into Superior Vena Cava, Open Approach [Same-MDC procedure]: “Insertion of Intraluminal Device into Superior Vena Cava, Open Approach — grouped in MDC 16, the procedure side of this code's crossing.” · check together
- 02HV3DZ — Insertion of Intraluminal Device into Superior Vena Cava, Percutaneous Approach [Same-MDC procedure]: “Insertion of Intraluminal Device into Superior Vena Cava, Percutaneous Approach — grouped in MDC 16, the procedure side of this code's crossing.” · check together
- 02HV42Z — Insertion of Monitoring Device into Superior Vena Cava, Percutaneous Endoscopic Approach [Same-MDC procedure]: “Insertion of Monitoring Device into Superior Vena Cava, Percutaneous Endoscopic Approach — grouped in MDC 16, the procedure side of this code's crossing.” · check together
- 02HV4DZ — Insertion of Intraluminal Device into Superior Vena Cava, Percutaneous Endoscopic Approach [Same-MDC procedure]: “Insertion of Intraluminal Device into Superior Vena Cava, Percutaneous Endoscopic Approach — grouped in MDC 16, the procedure side of this code's crossing.” · check together
- and 1609 more
Index entries
- Activation, mast cell (disorder) (syndrome), idiopathic[Index term]
Nearest codes (28)
- D89 — Other disorders involving the immune mechanism, not elsewhere classified [Sibling]
- D89.0 — Polyclonal hypergammaglobulinemia [Sibling]
- D89.1 — Cryoglobulinemia [Sibling]
- D89.2 — Hypergammaglobulinemia, unspecified [Sibling]
- D89.3 — Immune reconstitution syndrome [Sibling]
- D89.4 — Mast cell activation syndrome and related disorders [Sibling]
- D89.40 — Mast cell activation, unspecified [Sibling]
- D89.41 — Monoclonal mast cell activation syndrome [Sibling]
- and 20 more
Change history (3)
- FY2027 — Excludes2 note added [Change history]
- and 2 more
Nearest Codes in This Family
Official ICD-10-CM classifications closest to D89.42 in its code family, with their registry titles.
- D89.2 — Hypergammaglobulinemia, unspecified
- D89.3 — Immune reconstitution syndrome
- D89.4 — Mast cell activation syndrome and related disorders
- D89.40 — Mast cell activation, unspecified
- D89.41 — Monoclonal mast cell activation syndrome
- D89.43 — Secondary mast cell activation
- D89.44 — Hereditary alpha tryptasemia
- D89.49 — Other mast cell activation disorder
- D89.8 — Other specified disorders involving the immune mechanism, not elsewhere classified
- D89.81 — Graft-versus-host disease